These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 2105329)

  • 21. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.
    Hayes FJ; Taylor AE; Martin KA; Hall JE
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2343-9. PubMed ID: 9661606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potent pituitary-gonadal axis suppression and extremely low anaphylactoid activity of a new gonadotropin releasing hormone (GnRH) receptor antagonist "azaline B".
    Campen CA; Lai MT; Kraft P; Kirchner T; Phillips A; Hahn DW; Rivier J
    Biochem Pharmacol; 1995 May; 49(9):1313-21. PubMed ID: 7763313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach to assess changes in endocrine secretion: analysis of GnRH antagonist (Nal-Glu) suppression of gonadotropin release in ovariectomized ewes.
    Normolle DP; Evans NP; Dahl GE; Padmanabhan V
    Eur J Endocrinol; 1997 May; 136(5):519-30. PubMed ID: 9186273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged duration of gonadotropin inhibition by a third generation GnRH antagonist.
    Leal JA; Williams RF; Danforth DR; Gordon K; Hodgen GD
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1325-7. PubMed ID: 3142920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
    Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
    Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors.
    Klibanski A; Jameson JL; Biller BM; Crowley WF; Zervas NT; Rivier J; Vale WW; Bikkal H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):81-6. PubMed ID: 2535852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone differentially modulates gonadotropin subunit messenger ribonucleic acid responses to gonadotropin-releasing hormone pulse amplitude.
    Iliff-Sizemore SA; Ortolano GA; Haisenleder DJ; Dalkin AC; Krueger KA; Marshall JC
    Endocrinology; 1990 Dec; 127(6):2876-83. PubMed ID: 1701131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal responses to a potent gonadotropin hormone-releasing hormone antagonist in normal elderly men.
    Tenover JS; Dahl KD; Vale WW; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1990 Oct; 71(4):881-8. PubMed ID: 2205625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of testosterone on gonadotropin subunit messenger ribonucleic acids in the presence or absence of gonadotropin-releasing hormone.
    Winters SJ; Ishizaka K; Kitahara S; Troen P; Attardi B
    Endocrinology; 1992 Feb; 130(2):726-34. PubMed ID: 1370794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of gonadotropin subunit messenger ribonucleic acid expression by gonadotropin-releasing hormone pulse amplitude in vitro.
    Haisenleder DJ; Ortolano GA; Yasin M; Dalkin AC; Marshall JC
    Endocrinology; 1993 Mar; 132(3):1292-6. PubMed ID: 7679975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gonadotropin-releasing hormone on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for luteinizing hormone-beta gene stimulation.
    Shupnik MA
    Mol Endocrinol; 1990 Oct; 4(10):1444-50. PubMed ID: 2126596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrasts in the gonadotropin-releasing hormone dose-response relationships for luteinizing hormone, follicle-stimulating hormone and alpha-subunit release in young versus older men: appraisal with high-specificity immunoradiometric assay and deconvolution analysis.
    Zwart AD; Urban RJ; Odell WD; Veldhuis JD
    Eur J Endocrinol; 1996 Oct; 135(4):399-406. PubMed ID: 8921820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen selectively stimulates follicle-stimulating hormone-beta mRNA levels after gonadotropin-releasing hormone antagonist administration.
    Wierman ME; Wang C
    Biol Reprod; 1990 Mar; 42(3):563-71. PubMed ID: 2111188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin gene expression and secretion in gonadotropin-releasing hormone antagonist-treated male rats: effect of sex steroid replacement.
    Perheentupa A; Huhtaniemi I
    Endocrinology; 1990 Jun; 126(6):3204-9. PubMed ID: 1693570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.
    Hall JE; Taylor AE; Martin KA; Rivier J; Schoenfeld DA; Crowley WF
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):6894-8. PubMed ID: 8041716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differing responses of plasma bioactive and immunoreactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women.
    Matikainen T; Ding YQ; Vergara M; Huhtaniemi I; Couzinet B; Schaison G
    J Clin Endocrinol Metab; 1992 Sep; 75(3):820-5. PubMed ID: 1517372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of gonadotropin-releasing hormone pulse frequency on gonadotropin secretion and subunit messenger ribonucleic acids in perifused pituitary cells.
    Ishizaka K; Kitahara S; Oshima H; Troen P; Attardi B; Winters SJ
    Endocrinology; 1992 Mar; 130(3):1467-74. PubMed ID: 1537301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortisol regulates secretion and pituitary content of the two gonadotropins differentially in female rats: effects of gonadotropin-releasing hormone antagonist.
    Ringstrom SJ; Suter DE; Hostetler JP; Schwartz NB
    Endocrinology; 1992 Jun; 130(6):3122-8. PubMed ID: 1597133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.